©2024 - Stefano Forte
1. Chisari G, Martorana E, Lombardo SP, Raciti G, Giuffrida R, Bardelli A, Scionti D, Mare M, Picardo C, Deiana E, Memeo L, Colarossi C, Crisafulli G, Forte S. Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer. Clin Exp Med. 2025 Jun 30;25(1):222. doi: 10.1007/s10238-025-01762-4. PMID: 40586891.
2. Grisolia P, Tufano R, Iannarone C, De Falco A, Carlino F, Graziano C, Addeo R, Scrima M, Caraglia F, Ceccarelli A, Nuzzo PV, Cossu AM, Forte S, Giuffrida R, Orditura M, Caraglia M, Ceccarelli M. Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation. J Transl Med. 2024 Oct 15;22(1):938. doi: 10.1186/s12967-024-05734-2. PMID: 39407254; PMCID: PMC11476115.
3. Basilotta R, Casili G, Mannino D, Filippone A, Lanza M, Capra AP, Giosa D, Forte S, Colarossi L, Sciacca D, Esposito E, Paterniti I. Benzyl isothiocyanate suppresses development of thyroid carcinoma by regulating both autophagy and apoptosis pathway. iScience. 2024 Aug 23;27(10):110796. doi: 10.1016/j.isci.2024.110796. PMID: 39398237; PMCID: PMC11471196.
4. Martorana E, Raciti G, Giuffrida R, Bruno E, Ficarra V, Ludovico GM, Suardi NR, Iraci N, Leggio L, Bussolati B, Grange C, Lorico A, Leonardi R, Forte S. A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia. Cells. 2024 Jul 31;13(15):1286. doi: 10.3390/cells13151286. PMID: 39120316; PMCID: PMC11311686.
5. Ferini G, Fichera C, Boncoraglio A, Umana GE, Forte S. De Felice scheme: No risk at all of brain radionecrosis? Head Neck. 2024 Jul 3. doi: 10.1002/hed.27853. Epub ahead of print. PMID: 38958384.
6. Castorina P, Castiglione F, Ferini G, Forte S, Martorana E, Giuffrida D. Mathematical modeling of the synergistic interplay of radiotherapy and immunotherapy in anti-cancer treatments. Front Immunol. 2024 May 8;15:1373738. doi: 10.3389/fimmu.2024.1373738. PMID: 38779678; PMCID: PMC11109403.
7. Castorina P, Castiglione F, Ferini G, Forte S, Martorana E. Computational Approach for Spatially Fractionated Radiation Therapy (SFRT) and Immunological Response in Precision Radiation Therapy. J Pers Med. 2024 Apr 21;14(4):436. doi: 10.3390/jpm14040436. PMID: 38673063; PMCID: PMC11051362.
8. Privitera GF, Alaimo S, Caruso A, Ferro A, Forte S, Pulvirenti A. TMBcalc: a computational pipeline for identifying pan-cancer Tumor Mutational Burden gene signatures. Front Genet. 2024 Apr 5;15:1285305. doi: 10.3389/fgene.2024.1285305. PMID: 38645485; PMCID: PMC11026579.
9. Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu QL, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Ku'ulei-Lyn Faustino V, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ; MISEV Consortium; Théry C, Witwer KW. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404. Erratum in: J Extracell Vesicles. 2024 May;13(5):e12451. doi: 10.1002/jev2.12451. PMID: 38326288; PMCID: PMC10850029.
10. Ben Toumia I, Bachetti T, Chekir-Ghedira L, Profumo A, Ponassi M, Di Domizio A, Izzotti A, Sciacca S, Puglisi C, Forte S, Giuffrida R, Colarossi C, Milardi D, Grasso G, Lanza V, Fiordoro S, Drago G, Tkachenko K, Cardinali B, Romano P, Iervasi E, Vargas GC, Barboro P, Kohnke FH, Rosano C. Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology. Front Pharmacol. 2024 Jan 3;14:1258108. doi: 10.3389/fphar.2023.1258108. PMID: 38235113; PMCID: PMC10791888.
11. Scalia G, Ferini G, Marrone S, Salvati M, Yamamoto V, Kateb B, Schulte R, Forte S, Umana GE. Unexpected Transient Glioblastoma Regression in a Patient Previously Treated with Bacillus Calmette-Guérin Therapy: A Case Report and Immunomodulatory Effects Hypothesis. J Pers Med. 2023 Nov 28;13(12):1661. doi: 10.3390/jpm13121661. PMID: 38138888; PMCID: PMC10744726.
12. D'Aprile S, Denaro S, Pavone AM, Giallongo S, Giallongo C, Distefano A, Salvatorelli L, Torrisi F, Giuffrida R, Forte S, Tibullo D, Li Volti G, Magro G, Vicario N, Parenti R. Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance. J Transl Med. 2023 Nov 3;21(1):780. doi: 10.1186/s12967-023-04664-9. PMID: 37924062; PMCID: PMC10625232.
13. Arena GO, Forte S, Abdouh M, Vanier C, Corbeil D, Lorico A. Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis. Cells. 2023 Jun 6;12(12):1566. doi: 10.3390/cells12121566. PMID: 37371036; PMCID: PMC10297028.
14. Martorana E, Castorina P, Ferini G, Forte S, Mare M. Forecasting Individual Patients' Best Time for Surgery in Colon-Rectal Cancer by Tumor Regression during and after Neoadjuvant Radiochemotherapy. J Pers Med. 2023 May 18;13(5):851. doi: 10.3390/jpm13050851. PMID: 37241020; PMCID: PMC10220791.
15. Ferini G, Zagardo V, Critelli P, Santacaterina A, Sava S, Harikar MM, Venkataram T, Umana GE, Viola A, Valenti V, Forte S. Introducing Radiotherapy in Metastatic Merkel Cell Carcinoma Patients with Limited Progression on Avelumab: An Effective Step against Primary and Secondary Immune Resistance? J Pers Med. 2023 May 17;13(5):841. doi: 10.3390/jpm13050841. PMID: 37241012; PMCID: PMC10224079.
16. Natale G, Forte S, Messina G, Leonardi B, Mirra R, Leone F, Di Filippo V, Pica DG, Capasso F, Bove M, Noro A, Opromolla G, Martone M, De Angelis S, Fiorelli A. Intrathoracic neurogenic tumors (ITNs): Management of solid and cystic lesions. Thorac Cancer. 2023 Jul;14(19):1824-1830. doi: 10.1111/1759-7714.14927. Epub 2023 May 18. PMID: 37201908; PMCID: PMC10317589.
17. Pucci M, Moschetti M, Urzì O, Loria M, Conigliaro A, Di Bella MA, Crescitelli R, Olofsson Bagge R, Gallo A, Santos MF, Puglisi C, Forte S, Lorico A, Alessandro R, Fontana S. Colorectal cancer-derived small extracellular vesicles induce TGFβ1-mediated epithelial to mesenchymal transition of hepatocytes. Cancer Cell Int. 2023 Apr 18;23(1):77. doi: 10.1186/s12935-023-02916-8. PMID: 37072829; PMCID: PMC10114452.
18. Castorina P, Martorana E, Forte S. Dynamical Synergy of Drug Combinations during Cancer Chemotherapy. J Pers Med. 2022 Nov 9;12(11):1873. doi: 10.3390/jpm12111873. PMID: 36579581; PMCID: PMC9695902.
19. Fiorelli A, Forte S, Tolone S, Natale G, Santini M, Docimo L. Combined minimally invasive para-esophageal hernia repair and lobectomy for lung cancer. JTCVS Tech. 2022 Sep 20;16:157-159. doi: 10.1016/j.xjtc.2022.09.006. PMID: 36510511; PMCID: PMC9735385.
20. Leonardi B, Forte S, Natale G, Messina G, Rainone A, Opromolla G, Puca MA, Grande M, Martone M, Leone F, Fiorito R, Molino F, Liguori G, Russo F, Ferraro F, Pace MC, Molino A, Ferrante L, Forte M, Vicidomini G, Fiorelli A. One-lung ventilation in obese patients undergoing thoracoscopic lobectomy for lung cancer. Thorac Cancer. 2023 Jan;14(3):281-288. doi: 10.1111/1759-7714.14747. Epub 2022 Dec 7. PMID: 36479830; PMCID: PMC9870737.
21. Castrogiovanni P, Barbagallo I, Imbesi R, Musumeci G, Sanfilippo C, Broggi G, Caltabiano R, Tibullo D, Giallongo C, Forte S, Li Volti G, Di Rosa M. Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients. Pathol Res Pract. 2022 Sep;237:154038. doi: 10.1016/j.prp.2022.154038. Epub 2022 Jul 22. PMID: 35932496.
22. Longhitano L, Vicario N, Forte S, Giallongo C, Broggi G, Caltabiano R, Barbagallo GMV, Altieri R, Raciti G, Di Rosa M, Caruso M, Parenti R, Liso A, Busi F, Lolicato M, Mione MC, Li Volti G, Tibullo D. Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma. Cancer Immunol Immunother. 2022 Jun 3. doi: 10.1007/s00262-022-03215-3. Epub ahead of print. PMID: 35654889.
23. Ferini G, Forte S, Martorana E. Regarding 'Assessment of Upfront Selection Criteria to Prioritise Patients for Breath-Hold Left-Sided Breast Radiotherapy' by Tanna et al. Clin Oncol (R Coll Radiol). 2022 May 30:S0936-6555(22)00229-1. doi: 10.1016/j.clon.2022.05.008. Epub ahead of print. PMID: 35654668.
24. Ferini G, Palmisciano P, Forte S, Viola A, Martorana E, Parisi S, Valenti V, Fichera C, Umana GE, Pergolizzi S. Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy. Cancers (Basel). 2022 Apr 7;14(8):1871. doi: 10.3390/cancers14081871. PMID: 35454779; PMCID: PMC9032290.
25. Puglisi C, Giuffrida R, Borzì G, Illari S, Caronia FP, Di Mattia P, Colarossi C, Ferini G, Martorana E, Sette G, Eramo A, Lorico A, Di Grazia A, Forte S. Ex Vivo Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction In Vivo. Front Oncol. 2022 May 12;12:837400. doi: 10.3389/fonc.2022.837400. PMID: 35646627; PMCID: PMC9133629.
26. Castorina P, Ferini G, Martorana E, Forte S. Tumor Volume Regression during and after Radiochemotherapy: A Macroscopic Description. J Pers Med. 2022 Mar 26;12(4):530. doi: 10.3390/jpm12040530. PMID: 35455646; PMCID: PMC9025192.
27. Scuderi, S.A.; Calabrese, G.; Paterniti, I.; Campolo, M.; Lanza, M.; Capra, A.P.; Pantaleo, L.; Munaò, S.; Colarossi, L.; Forte, S.; Cuzzocrea, S.; Esposito, E. The Biological Function of MicroRNAs in Bone Tumors. Int. J. Mol. Sci. 2022, 23, 2348. https://doi.org/10.3390/ijms23042348
28. Longhitano, L.; Forte, S.; Orlando, L.; Grasso, S.; Barbato, A.; Vicario, N.; Parenti, R.; Fontana, P.; Amorini, A.M.; Lazzarino, G.; Li Volti, G.; Di Rosa, M.; Liso, A.; Tavazzi, B.; Lazzarino, G.; Tibullo, D. The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress. Antioxidants 2022, 11, 275. https://doi.org/10.3390/antiox11020275
29. Calabrese G, De Luca G, Nocito G, Rizzo MG, Lombardo SP, Chisari G, Forte S, Sciuto EL, Conoci S. Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors. Int J Mol Sci. 2021 Oct 29;22(21):11783. doi: 10.3390/ijms222111783. PMID: 34769212; PMCID: PMC8583729.
30. Esposito F, Giuffrida R, Raciti G, Puglisi C, Forte S. Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy. Int J Mol Sci. 2021 Oct 1;22(19):10689. doi: 10.3390/ijms221910689. PMID: 34639030; PMCID: PMC8508993.
31. Scuderi SA, Casili G, Ardizzone A, Forte S, Colarossi L, Sava S, Paterniti I, Esposito E, Cuzzocrea S, Campolo M. KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation. Cancers (Basel). 2021 Jul 9;13(14):3444. doi: 10.3390/cancers13143444. PMID: 34298658; PMCID: PMC8306782.
32. Nocito G, Calabrese G, Forte S, Petralia S, Puglisi C, Campolo M, Esposito E, Conoci S. Carbon Dots as Promising Tools for Cancer Diagnosis and Therapy. Cancers (Basel). 2021 Apr 21;13(9):1991. doi: 10.3390/cancers13091991. PMID: 33919096
33. Fiorelli A, Forte S, Natale G, Santini M, Fang W. Handling benign interlobar lymphadenopathy during thoracoscopic lobectomy. Thorac Cancer. 2021 Apr 3. doi: 10.1111/1759-7714.13949. Epub ahead of print. PMID: 33811459.
34. Puglisi C, Giuffrida R, Borzì G, Di Mattia P, Costa A, Colarossi C, Deiana E, Picardo MC, Colarossi L, Mare M, Marino L, Di Grazia A, Forte S. Radiosensitivity of Cancer Stem Cells Has Potential Predictive Value for Individual Responses to Radiotherapy in Locally Advanced Rectal Cancer. Cancers (Basel). 2020 Dec 7;12(12):E3672. doi: 10.3390/cancers12123672. PMID: 33297488.
35. Fiorelli A, Forte S, Caronia FP, Ferrigno F, Santini M, Petersen RH, Fang W. Is video-assisted thoracoscopic lobectomy associated with higher overall costs compared with open surgery? Results of best evidence topic analysis. Thorac Cancer. 2021 Feb 5. doi: 10.1111/1759-7714.13708. Epub ahead of print. PMID: 33544445.
36. Calabrese G, Petralia S, Fabbi C, Forte S, Franco D, Guglielmino S, Esposito E, Cuzzocrea S, Traina F, Conoci S. Au, Pd and maghemite nanofunctionalized hydroxyapatite scaffolds for bone regeneration. Regen Biomater. 2020 Aug 27;7(5):461-469. doi: 10.1093/rb/rbaa033. PMID: 33149935; PMCID: PMC7597806.
37. Veschi V, Verona F, Lo Iacono M, D'Accardo C, Porcelli G, Turdo A, Gaggianesi M, Forte S, Giuffrida D, Memeo L, Todaro M. Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis. Front Endocrinol (Lausanne). 2020 Aug 25;11:566. doi: 10.3389/fendo.2020.00566. PMID: 32982967
38. Cesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, Alessandro Barbato, Nunzio Vicario, Daniela Cambria, Nunziatina Laura Parrinello, Alessandra Romano 3, Concetta Conticello, Stefano Forte, Rosalba Parenti, Angela Maria Amorini, Giuseppe Lazzarino, Giovanni Li Volti, Giuseppe Alberto Palumbo and Francesco Di Raimondo. Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells. Cancers (Basel). 2020;12(8):E1999. Published 2020 Jul 22. doi:10.3390/cancers12081999. PMID: 32707760
39. Turdo A, Porcelli G, D'Accardo C, Franco SD, Verona F, Forte S, Giuffrida D, Memeo L, Todaro M, Stassi G. Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities. Cancers (Basel). 2020 May 31;12(6):E1436. doi: 10.3390/cancers12061436. PMID: 32486505
40. Szychlinska MA, Calabrese G, Ravalli S, Parrinello NL, Forte S, Castrogiovanni P, Pricoco E, Imbesi R, Castorina S, Leonardi R, Di Rosa M, Musumeci G. Cycloastragenol as an Exogenous Enhancer of Chondrogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. A Morphological Study. Cells 2020, 9, 347.
41. Lemaire Q, Raffo-Romero A, Arab T, Drago F, Forte S, Gimeno JP, Begard S, Colin M, Vizoli J, Sautière PE, Salzet M, Lefebvre C. Isolation of microglia-derived extracellular vesicles: towards miRNA signatures and neuroprotection. J Nanobiotechnol 17, 119 (2019) doi:10.1186/s12951-019-0551-6
42. Calabrese G, Dolcimascolo A, Caruso G, Forte S. miR-19a Is Involved In Progression And Malignancy Of Anaplastic Thyroid Cancer Cells. OncoTargets and Therapy. 2019 Nov 13, 12:9571-9583. DOI https://doi.org/10.2147/OTT.S221733. PMID: 32009794.
43. Giuffrida D, Giuffrida R, Puliafito I, Vella V, Memeo L, Puglisi C, Regalbuto C, Pellegriti G, Forte S and Belfiore A. Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer. International Journal of Surgical Oncology, vol. 2019, Article ID 2715260, 7 pages, 2019. https://doi.org/10.1155/2019/2715260.
44. Rappa G, Puglisi C, Santos MF, Forte S, Memeo L, Lorico A. Extracellular Vesicles from Thyroid Carcinoma: The New Frontier of Liquid Biopsy. Int J Mol Sci. 2019 Mar 5;20(5). pii: E1114. doi: 10.3390/ijms20051114. Review. PubMed PMID: 30841521
45. Stella S, Zammit V, Vitale SR, Pennisi MS, Massimino M, Tirrò E, Forte S, Spitaleri A, Antolino A, Siracusa S, Accurso V, Mannina D, Impera S, Musolino C, Russo S, Malato A, Mineo G, Musso M, Porretto F, Martino B, Di Raimondo F, Manzella L, Vigneri P, Stagno F. Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib. Int J Mol Sci. 2019 May 6;20(9). pii: E2226. doi: 10.3390/ijms20092226. PubMed PMID: 31064152
46. Calabrese G, Gulino R, Giuffrida R, Forte S, Figallo E, Fabbi C, Salvatorelli L, Memeo L, Gulisano M, Parenti R. In Vivo Evaluation of Biocompatibility and Chondrogenic Potential of a Cell-Free Collagen-Based Scaffold. Front Physiol. 2017 Nov 29;8:984. doi: 10.3389/fphys.2017.00984. eCollection 2017. PubMed PMID: 29238307
47. Vigneri P, Stagno F, Stella S, Cupri A, Forte S, Massimino M, Antolino A, Siragusa S, Mannina D, Impera SS, Musolino C, Malato A, Mineo G, Tomaselli C, Murgano P, Musso M, Morabito F, Molica S, Martino B, Manzella L, Müller MC, Hochhaus A, Di Raimondo F. High BCR-ABL/GUSis levels at diagnosis of chronic phase cml are associated with unfavorable responses to standard-dose imatinib. Clin Cancer Res. 2017 Sep 19. pii: clincanres.0962.2017. doi: 10.1158/1078-0432.CCR-17-0962. [Epub ahead of print] PubMed PMID: 28928163.
48. Calabrese G, Giuffrida R, Forte S, Fabbi C, Figallo E, Salvatorelli L, Memeo L, Parenti R, Gulisano M, Gulino R. Human adipose-derived mesenchymal stem cells seeded into a collagen-hydroxyapatite scaffold promote bone augmentation after implantation in the mouse. Sci Rep. 2017 Aug 2;7(1):7110. doi: 10.1038/s41598-017-07672-0. PubMed PMID: 28769083.
49. Zito G, Naselli F, Saieva L, Raimondo S, Calabrese G, Guzzardo C, Forte S, Rolfo C, Parenti R, Alessandro R. Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition. Sci Rep. 2017 Jul 6;7(1):4770. doi: 10.1038/s41598-017-05047-z. PubMed PMID: 28684780; PubMed Central PMCID: PMC5500497
50. Vicario N, Calabrese G, Zappalà A, Parenti C, Forte S, Graziano ACE, Vanella L, Pellitteri R, Cardile V, Parenti R. Inhibition of Cx43 mediates protective effects on hypoxic/reoxygenated human neuroblastoma cells. J Cell Mol Med. 2017 May 9. doi: 10.1111/jcmm.13177. [Epub ahead of print] PubMed PMID: 28488330.
51. Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M. MicroRNA-based molecular classification of papillary thyroid carcinoma. Int J Oncol. 2017 May;50(5):1767-1777. doi: 10.3892/ijo.2017.3960. Epub 2017 Apr 7. PubMed PMID: 28393181.
52. Li Volti G, Tibullo D, Vanella L, Giallongo C, Di Raimondo F, Forte S, Di Rosa M, Signorelli SS, Barbagallo I. The heme oxygenase system in hematological malignancies. Antioxid Redox Signal. 2017 Aug 20;27(6):363-377. doi: 10.1089/ars.2016.6735. Epub 2017 May 19. PubMed PMID: 28257621.
53. Calabrese G, Forte S, Gulino R, Cefalì F, Figallo E, Salvatorelli L, Maniscalchi ET, Angelico G, Parenti R, Gulisano M, Memeo L, Giuffrida R. Combination of Collagen-Based Scaffold and Bioactive Factors Induces Adipose-Derived Mesenchymal Stem Cells Chondrogenic Differentiation In vitro. Front Physiol. 2017 Feb 2;8:50. doi: 10.3389/fphys.2017.00050. PubMed PMID: 28210226.
54. Bellavia D, Raimondo S, Calabrese G, Forte S, Cristaldi M, Patinella A, Memeo L, Manno M, Raccosta S, Diana P, Cirrincione G, Giavaresi G, Monteleone F, Fontana S, De Leo G, Alessandro R. Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth. Theranostics 2017; 7(5):1333-1345. doi:10.7150/thno.17092
55. Calabrese G, Giuffrida R, Forte S, Salvatorelli L, Fabbi C, Figallo E, Gulisano M, Parenti R, Magro G, Colarossi C, Memeo L, Gulino R. Bone augmentation after ectopic implantation of a cell-free collagen-hydroxyapatite scaffold in the mouse. Sci Rep. 2016 Nov 8;6:36399. doi: 10.1038/srep36399. PubMed PMID: 27821853; PubMed Central PMCID: PMC5099581.
56. Vicari L, La Rosa C, Forte S, Calabrese G, Colarossi C, Aiello E, Salluzzo S, Memeo L. Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma. Onco Targets Ther. 2016 Oct 11;9:6225-6231. PubMed PMID: 27785070;
57. Vanella L, Barbagallo I, Tibullo D, Forte S, Zappalà A, Li Volti G. The non-canonical functions of the heme oxygenases. Oncotarget. 2016 Oct 18;7(42):69075-69086. doi: 10.18632/oncotarget.11923. Review. PubMed PMID: 27626166.
58. Calabrese G, Giuffrida R, Fabbi C, Figallo E, Lo Furno D, Gulino R, Colarossi C, Fullone F, Giuffrida R, Parenti R, Memeo L, Forte S. Collagen-Hydroxyapatite Scaffolds Induce Human Adipose Derived Stem Cells Osteogenic Differentiation In Vitro. PLoS One. 2016 Mar 16;11(3):e0151181. doi: 10.1371/journal.pone.0151181. eCollection 2016. PubMed PMID: 26982592.
59. Vicari L, Calabrese G, Forte S, Giuffrida R, Colarossi C, Parrinello NL, Memeo L. Potential Role of Activating Transcription Factor 5 during Osteogenesis. Stem Cells Int. 2016;2016:5282185. doi: 10.1155/2016/5282185. Epub 2015 Dec 6. PubMed PMID: 26770207; PubMed Central PMCID: PMC4684884.
60. Romano GL, Platania CB, Forte S, Salomone S, Drago F, Bucolo C. MicroRNA target prediction in glaucoma. Prog Brain Res. 2015;220:217-40. doi: 10.1016/bs.pbr.2015.04.013. Epub 2015 Jun 30. PubMed PMID: 26497793.
61. Romano A, Parrinello NL, Consoli ML, Marchionni L, Forte S, Conticello C, Pompa A, Corso A, Milone G, Di Raimondo F, Borrello I. Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents. Ann Hematol 2015 DOI 10.1007/s00277-015-2462-4- Pubmed. PMID: 26223359
62. Calabrese G, Giuffrida R, Lo Furno D, Parrinello NL, Forte S, Gulino G, Colarossi C, Schinocca LR, Giuffrida R, Cardile V, Memeo L. Potential Effect ofCD271 on Human Mesenchymal Stromal Cell Proliferation and Differentiation. Int. J. Mol. Sci. 2015, 16(7), 15609-15624; doi:10.3390/ijms160715609. PubMed PMID: 26184166
63. Narayanan KB, Ali M, Barclay BJ, Cheng Q, D'Abronzo L, Dornetshuber-Fleiss R, Ghosh PM, Gonzalez Guzman MJ, Lee TJ, Leung PS, Li L, Luanpitpong S, RatovitskiE, Rojanasakul Y, Romano MF, Romano S, Sinha RK, Yedjou C, Al-Mulla F, Al-TemaimiR, Amedei A, Brown DG, Ryan EP, Colacci A, Hamid RA, Mondello C, Raju J, SalemHK, Woodrick J, Scovassi I, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Kim SY, Bisson WH, Lowe L, Park HH. Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death. Carcinogenesis. 2015 Jun;36Suppl 1:S89-S110. doi: 10.1093/carcin/bgv032. Review. PubMed PMID: 26106145.
64. Langie SA, Koppen G, Desaulniers D, Al-Mulla F, Al-Temaimi R, Amedei A,Azqueta A, Bisson WH, Brown D, Brunborg G, Charles AK, Chen T, Colacci A,Darroudi F, Forte S, Gonzalez L, Hamid RA, Knudsen LE, Leyns L, Lopez de CerainSalsamendi A, Memeo L, Mondello C, Mothersill C, Olsen AK, Pavanello S, Raju J,Rojas E, Roy R, Ryan E, Ostrosky-Wegman P, Salem HK, Scovassi I, Singh N, VaccariM, Van Schooten FJ, Valverde M, Woodrick J, Zhang L, van Larebeke N,Kirsch-Volders M, Collins AR. Causes of genome instability: the effect of lowdose chemical exposures in modern society. Carcinogenesis. 2015 Jun;36 Suppl1:S61-88. doi: 10.1093/carcin/bgv031. Review. PubMed PMID: 26106144.
65. Engström W, Darbre P, Eriksson S, Gulliver L, Hultman T, Karamouzis MV,Klaunig JE, Mehta R, Moorwood K, Sanderson T, Sone H, Vadgama P, Wagemaker G,Ward A, Singh N, Al-Mulla F, Al-Temaimi R, Amedei A, Colacci AM, Vaccari M,Mondello C, Scovassi AI, Raju J, Hamid RA, Memeo L, Forte S, Roy R, Woodrick J,Salem HK, Ryan E, Brown DG, Bisson WH. The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling. Carcinogenesis. 2015 Jun;36 Suppl 1:S38-60. doi:10.1093/carcin/bgv030. Review. PubMed PMID: 26106143.
66. Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez deCerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK,Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, ZhouBP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C,Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F,Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami G, CalafGM, Williams G, WolfGT, Koppen G, Brunborg G, Kim Lyerly H,Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH,Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondráček J, Raju J, Roman J,Wise JP Sr, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-LealJF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA,Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L,McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M,Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart M, Xia M,Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N,Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky- Wegman P, Thompson P, Dent P,Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB,Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R,Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, AbdHamid R, Langie SA, Eltom S, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA,Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T,Dormoy V, Odero- Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W,Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z. Assessing thecarcinogenic potential oflow-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis. 2015 Jun;36 Suppl 1:S254-96.doi: 10.1093/carcin/bgv039. Review. PubMed PMID: 26106142.
67. Thompson PA, Khatami M, Baglole CJ, Sun J, Harris S, Moon EY, Al-Mulla F,Al-Temaimi R, Brown D, Colacci A, Mondello C, Raju J, Ryan E, Woodrick J,Scovassi I, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A,Hamid RA, Lowe L, Guarnieri T, Bisson WH. Environmental immune disruptors,inflammation and cancer risk. Carcinogenesis. 2015 Jun;36 Suppl 1:S232-53. doi:10.1093/carcin/bgv038. Review. PubMed PMID: 26106141.
68. Brooks Robey R, Weisz J, Kuemmerle N, Salzberg AC, Berg A, G Brown D, Kubik L,Palorini R, Al-Mulla F, Al-Temaimi R, Colacci A, Mondello C, Raju J, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A,Hamid RA, Williams GP, Lowe L, Meyer J, Martin FL, Bisson WH, Chiaradonna F, RyanEP. Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis? Carcinogenesis. 2015 Jun;36 Suppl1:S203-31. doi: 10.1093/carcin/bgv037. Review. PubMed PMID: 26106140.
69. Nahta R, Al-Mulla F, Al-Temaimi R, Amedei A, Andrade-Vieira R, Bay S, G Brown D, Calaf GM, Castellino RC, Cohen-Solal KA, Colacci A, Cruickshanks N, Dent P, DiFiore R, Forte S, Goldberg GS, Hamid RA, Krishnan H, Laird DW, Lasfar A,Marignani PA, Memeo L, Mondello C, Naus CC, Ponce-Cusi R, Raju J, Roy D, Roy R, PRyan E, Salem HK, Scovassi AI, Singh N, Vaccari M, Vento R, Vondráček J, Wade M, Woodrick J, Bisson WH. Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression. Carcinogenesis. 2015 Jun;36Suppl 1:S2-S18. doi: 10.1093/carcin/bgv028. Review. PubMed PMID: 26106139.
70. Carnero A, Blanco-Aparicio C, Kondoh H, Lleonart ME, Martinez-Leal JF,Mondello C, Ivana Scovassi A, Bisson WH, Amedei A, Roy R, Woodrick J, Colacci A, Vaccari M, Raju J, Al-Mulla F, Al-Temaimi R, Salem HK, Memeo L, Forte S, Singh N,Hamid RA, Ryan EP, Brown DG, Wise JP Sr, Wise SS, Yasaei H. Disruptive chemicals, senescence and immortality. Carcinogenesis. 2015 Jun;36 Suppl 1:S19-37. doi:10.1093/carcin/bgv029. Review. PubMed PMID: 26106138.
71. Hu Z, Brooks S A,Dormoy V, Hsu CW, Hsu HY, Lin LT, Massfelder T, Rathmell WK, Xia M, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Prudhomme KR, Colacci A,Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Lowe L, Jensen L, Bisson WH, KleinstreuerN. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis. 2015 Jun;36 Suppl 1:S184-202. doi: 10.1093/carcin/bgv036. Review. PubMed PMID: 26106137.
72. Casey SC, Vaccari M, Al-Mulla F, Al-Temaimi R, Amedei A, Barcellos-HoffMH,Brown DG, Chapellier M, Christopher J, Curran C, Forte S, Hamid RA, Heneberg P,Koch DC, Krishnakumar PK, Laconi E, Maguer-Satta V, Marongiu F, Memeo L, MondelloC, Raju J, Roman J, Roy R, Ryan EP, Ryeom S, Salem HK, Scovassi AI, Singh N,Soucek L, Vermeulen L, Whitfield JR, Woodrick J, Colacci A, Bisson WH, FelsherDW. The effect ofenvironmental chemicals on the tumor microenvironment. Carcinogenesis. 2015 Jun;36 Suppl 1:S160-83. doi: 10.1093/carcin/bgv035. Review. PubMed PMID: 26106136.
73. Ochieng J, Nangami GN, Ogunkua O, Miousse IR, Koturbash I, Odero-Marah V,McCawley L, Nangia-Makker P, Ahmed N, Luqmani Y, Chen Z, Papagerakis S, WolfGT, Dong C, Zhou BP, Brown DG, Colacci A, Hamid RA, Mondello C, Raju J, Ryan EP,Woodrick J, Scovassi I, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK,Amedei A, Al-Temaimi R, Al-Mulla F, Bisson WH, Eltom SE. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis. 2015 Jun;36 Suppl 1:S128-59. doi: 10.1093/carcin/bgv034. Review. PubMed PMID: 26106135.
74. Kravchenko J, Corsini E, Williams MA, Decker W, Manjili MH, Otsuki T, SinghN, Al-Mulla F, Al-Temaimi R, Amedei A, Colacci AM, Vaccari M, Mondello C,Scovassi AI, Raju J, Hamid RA, Memeo L, Forte S, Roy R, Woodrick J, Salem HK,Ryan EP, Brown DG, Bisson WH, Lowe L, Lyerly HK. Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions. Carcinogenesis. 2015 Jun;36 Suppl 1:S111-27. doi: 10.1093/carcin/bgv033. Epub2015 May 22. Review. PubMed PMID: 26002081.
75. Forte S, La Rosa C, Pecce V, Rosignolo F, Memeo L. The role ofmicroRNAs in thyroid carcinomas. Anticancer Res. 2015 Apr;35(4):2037-47. Review. PubMed PMID: 25862858.
76. Gulino R, Forte S, Parenti R, Memeo L, Gulisano M. MicroRNA and pediatric tumors: Future perspectives. Acta Histochem. 2015 May-Jun;117(4-5):339-354. doi: 10.1016/j.acthis.2015.02.007. Epub 2015 Mar 9. Review. PubMed PMID: 25765112.
77. Gulino R, Forte S, Parenti R, Gulisano M. TDP-43 as a Modulator of Synaptic Plasticity in a Mouse Model of Spinal Motoneuron Degeneration. CNS Neurol Disord Drug Targets. 2015;14(1):55-60. PubMed PMID: 25613499.
78. Forte S, Pagliuca A, Maniscalchi ET, Gulino R, Calabrese G, Ricci-Vitiani L, Pallini R, Signore M, Parenti R, De Maria R, Gulisano M. Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model. PLoS One. 2013 Dec 12;8(12):e81432. doi:10.1371/journal.pone.0081432. eCollection 2013. PubMed PMID: 24349068; PubMed Central PMCID: PMC3861258.
79. Romano A, Parrinello NL, Vetro C, Forte S, Chiarenza A, Figuera A, Motta G,Palumbo GA, Ippolito M, Consoli U, Di Raimondo F. Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy. Br J Haematol. 2015Mar;168(5):689-700. doi: 10.1111/bjh.13198. Epub 2014 Nov 7. PubMed PMID:25376846.
80. Vanella L, Li Volti G, Guccione S, Rappazzo G, Salvo E, Pappalardo M, Forte S, Schwartzman ML, Abraham NG. Heme oxygenase-2/adiponectin protein-protein interaction in metabolic syndrome. Biochem Biophys Res Commun. 2013 Mar22;432(4):606-11. doi: 10.1016/j.bbrc.2013.02.037. Epub 2013 Feb 21. PubMed PMID:23438433.
81. Romano A, Chiarenza A, Consoli U, Conticello C, Forte S, Uccello G, Vetro C, Cavalli M, Coppolino F, Palumbo GA, Di Raimondo F. Intravenous injection ofbortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma. Ann Oncol. 2013 Apr;24(4):1038-44. doi: 10.1093/annonc/mds531. Epub 2012Nov 7. PubMed PMID: 23136226.
82. Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, Runci D, Forte S, De Maria R, Ricci-Vitiani L. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene. 2013 Oct;32(40):4806-13. doi: 10.1038/onc.2012.495.Epub 2012 Nov 5. PubMed PMID: 23128394.
83. Romano A, Vetro C, Donnarumma D, Forte S, Ippolito M, Di Raimondo F. Early interim 2- (1)fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to peripheral blood lymphocyte/monocyte ratio at diagnosis in classical Hodgkin's lymphoma. Haematologica. 2012 Jun;97(6):e21-3;author reply e24. doi: 10.3324/haematol.2012.064576. PubMed PMID: 22665531;PubMed Central PMCID: PMC3366667.
84. Laganà A, Forte S, Russo F, Giugno R, Pulvirenti A, Ferro A. Prediction ofhuman targets for viral-encoded microRNAs by thermodynamics and empirical constraints. J RNAi Gene Silencing. 2010 May 24;6(1):379-85. PubMed PMID:20628498; PubMed Central PMCID: PMC2902144.
85. Laganà A, Forte S, Giudice A, Arena MR, Puglisi PL, Giugno R, Pulvirenti A,Shasha D, Ferro A. miRò: a miRNA knowledge base. Database (Oxford).2009;2009:bap008. Epub 2009 Aug 4. PubMed PMID: 20157481; PubMed Central PMCID:PMC2794794.
86. Li Volti G, Galvano F, Frigiola A, Guccione S, Di Giacomo C, Forte S, Tringali G, Caruso M, Adekoya OA, Gazzolo D. Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach. J Nutr Biochem. 2010 Sep;21(9):865-71. doi:10.1016/j.jnutbio.2009.06.011. Epub 2009 Oct 31. PubMed PMID: 19879747.
87. Di Pietro C, Ragusa M, Barbagallo D, Duro LR, Guglielmino MR, Majorana A,Giunta V, Rapisarda A, Tricarichi E, Miceli M, Angelica R, Grillo A, Banelli B, Defferari I, Forte S, Laganà A, Bosco C, Giugno R, Pulvirenti A, Ferro A,Grzeschik KH, Di Cataldo A, Tonini GP, Romani M, Purrello M. Involvement of GTA protein NC2beta in neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation. Mol Cancer. 2008 Jun6;7:52. doi: 10.1186/1476-4598-7-52. Erratum in: Mol Cancer. 2008;7. doi:10.1186/1476-4598-7-59. PubMed PMID: 18538002; PubMed Central PMCID: PMC2443168.
88. Pignatello R, Guccione S, Forte S, Di Giacomo C, Sorrenti V, Vicari L, Uccello Barretta G, Balzano F, Puglisi G. Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling. Bioorg Med Chem. 2004 Jun 1;12(11):2951-64.PubMed PMID: 15142554.
89. Librando V, Forte S, Sarpietro MG. Structure effect on the interaction of phenylurea herbicides with model biomembrane as an environmental mobility parameter. Environ Sci Technol. 2004 Jan 15;38(2):503-7. PubMed PMID: 14750726.
©2024 - Stefano Forte